tm
Seeing Is Believing
tm
Seeing Is Believing
ALLO is currently covered by 14 analysts with an average potential upside of $13.51 (95.76%) backed by displayed 55 price targets and 98 ratings.
Analysts average stock forecasts to be materialized ratio is 35.09% with an average time for these price targets to be met of 76.53 days.
Highest price target for ALLO is 25, Lowest price target is 5, average price target is 15.
Most recent stock forecast was given by MARK BREIDENBACH from OPPENHEIMER on 03-Aug-2023. First documented stock forecast 15-Mar-2019.
Currently, out of the existing stock ratings of ALLO - 8 which are a Hold (16.33%), 41 which are a Buy (83.67%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
28
$24.61 (725.96%)
28
1 months 25 days ago
2/9 (22.22%)
$17.97 (165.58%)
194
Buy
18
$14.61 (430.97%)
20
2 months 16 days ago
2/9 (22.22%)
$10.36 (97.27%)
93
Buy
35
$31.61 (932.45%)
55
3 months 12 days ago
1/3 (33.33%)
$24.87 (286.09%)
192
Buy
15
$11.61 (342.48%)
19
3 months 23 days ago
2/7 (28.57%)
$11.18 (121.55%)
106
Buy
32
6 months 27 days ago
3/5 (60%)
$8.07 (50.72%)
43
What is ALLO (Allogene Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?
Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?
Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?
